Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis-Reference-Cited by-同舟云学术

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

Published:2020-10-07 Issue:11 Volume:4 Page:1578-1590
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol. Commun.

Author:

Witjes Julia J.¹,Smits Loek P.¹,Pekmez Ceyda T.²,Prodan Andrei¹,Meijnikman Abraham S.¹,Troelstra Marian A.³,Bouter Kristien E.C.¹,Herrema Hilde¹,Levin Evgeni¹,Holleboom Adriaan G.¹,Winkelmeijer Maaike¹,Beuers Ulrich H.⁴,Lienden Krijn³,Aron‐Wisnewky Judith¹,Mannisto Ville¹,Bergman Jacques J.⁴,Runge Jurgen H.³,Nederveen Aart J.³,Dragsted Lars O.²,Konstanti Prokopis⁵,Zoetendal Erwin G.⁵,Vos Willem⁵⁶,Verheij Joanne⁷,Groen Albert K.¹⁸,Nieuwdorp Max¹

Affiliation:

1. Department of Internal and Vascular Medicine Amsterdam University Medical CentersLocation AMC Amsterdam the Netherlands

2. Department of Nutrition, Exercise and Sports University of Copenhagen Copenhagen Denmark

3. Department of Radiology & Nuclear Medicine Amsterdam University Medical CentersLocation AMC Amsterdam the Netherlands

4. Department of Gastroenterology and Hepatology Amsterdam University Medical CentersLocation AMC Amsterdam the Netherlands

5. Laboratory of Microbiology Wageningen University Wageningen the Netherlands

6. Faculty of Medicine Human Microbiome Research ProgramUniversity of Helsinki Finland

7. Department of Pathology Amsterdam University Medical CentersLocation AMC Amsterdam the Netherlands

8. Department of Laboratory Medicine University of GroningenUniversity Medical Center Groningen the Netherlands

Funder

Hartstichting

Fondation Leducq

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1601

Reference50 articles.

1. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

3. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

5. Back to Byzance: Querelles byzantines over NASH and fibrosis

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ammonia-induced stress response in liver disease progression and hepatic encephalopathy;Nature Reviews Gastroenterology & Hepatology;2024-09-09

2. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges;Engineering;2024-09

3. The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review;Biomedicines;2024-08-16

4. Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact;Hepatology International;2024-07-12

5. Human Gut Microbiota in Cardiovascular Disease;Comprehensive Physiology;2024-06-27